The MRI fusion guided prostate biopsy “fuses” MRI scans with real-time ultrasound images of the prostate. This cutting-edge biopsy system allows us here at the Dr. David Samadi Prostate Cancer Center to pinpoint specific tumors within the prostate gland. This information provides the patient with the most optimal treatment plan and best possible outcome in detecting and diagnosing prostate cancer.
Read MoreA PCA3 (prostate cancer gene 3) test is a simple urine test used to predict the likelihood of prostate cancer. Specifically, it is an additional tool used to determine whether a prostate biopsy is necessary. The PCA3 is specific for prostate cancer as the prostate cancer gene is only produced by prostate cancer cells.
Read MoreConsider these facts on prostate cancer. More than 200,000 men will develop prostate cancer this year, making it the #1 cancer in men after skin cancer. Almost 30,000 men will die of prostate cancer, second only to lung cancer. Detecting and treating prostate cancer early is the key to cure. Unfortunately prostate cancer screening guidelines vary among organizations with no universally accepted standard. As a consequence this has created confusion among patients and caregivers alike. The importance of being an educated patient has never been greater.
Read More
